Digital Self-Management for Inflammatory Bowel Disease

This trial explores whether a digital program can help people manage their inflammatory bowel disease (IBD) and improve their daily lives. The researchers aim to determine if combining this digital self-management program with standard care can positively impact how participants feel and manage their condition. Participants will receive either regular care or regular care plus access to the digital self-management program for 24 weeks. Individuals diagnosed with IBD, who experience regular symptoms, and whose quality of life is affected by the condition might be a good fit for this trial. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance IBD management and improve quality of life.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Research has shown that digital self-management programs for inflammatory bowel disease (IBD) are generally safe for participants. For example, a review of several digital health tools used in IBD care found that patients tolerated them well. These programs reported no major side effects, suggesting they are safe to use alongside regular treatment.

One study examined the MyGut digital health monitoring platform, which was added to IBD care without causing harm. This indicates that digital tools can safely complement traditional treatments for IBD.

Researchers are excited about the digital self-management program for inflammatory bowel disease (IBD) because it offers a novel way for patients to actively manage their condition. Unlike traditional treatments like medication or dietary changes, this program empowers patients with digital tools to track symptoms, manage stress, and adjust lifestyle choices in real-time. Additionally, integrating this program with standard care could enhance treatment outcomes by providing personalized support and fostering better patient engagement. This innovative approach has the potential to improve quality of life and long-term disease management for individuals with IBD.

Research shows that digital self-management programs can help people with inflammatory bowel disease (IBD). In this trial, participants will receive either standard care or standard care plus a digital self-management program. Studies have found that these programs can improve patients' quality of life and reduce symptoms. A review of various studies found that digital health tools aid in managing IBD by promoting regular medication adherence and reducing emergency visits. Another study found that patients using digital tools felt more energetic and healthier overall. These findings suggest that digital self-management could effectively manage IBD symptoms.²⁶⁷⁸⁹